FDA Adverse Event Injury Summary report: N

ONETOUCHPING GLUCOSEMGMTSYSTEM

MDR report key: 3061367 · Received April 16, 2013

Report

Report Number
2531779-2013-04342
Event Type
Injury
Date Received
April 16, 2013
Date of Event
March 19, 2013
Report Date
March 19, 2013
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K080639
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4) - DEVICE EVALUATION: THE PUMP WAS RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON (B)(4) 2013 WITH THE FOLLOWING FINDINGS: THE BLACK BOX SHOWED A MANUAL TIME CHANGE FROM (B)(4) 2013 18:49 TO (B)(4) 2013 17:49; THERE WAS NO PUMP-INITIATED TIME CHANGE PRIOR TO THIS MANUAL RESET. THE TOTAL DAILY DOSE TOTALS ADDED UP CORRECTLY AND REFLECTED THE USERS PROGRAMMED BASAL RATES. ONLY TYPICAL USAGE ALARMS AND WARNINGS WERE OBSERVED. THE PUMP SUCCESSFULLY COMPLETED AND PASSED THE REQUIRED 29-HOUR FLOW ACCURACY TEST AND WAS FOUND TO BE DELIVERING WITHIN THE SPECIFICATION. A PINKISH CONTRAST WAS OBSERVED ON THE DISPLAY SCREEN. THE PUMP COVER WAS REMOVED AND THE PINK DISPLAY WAS REPLACED WITH A TEST DISPLAY. THE TEST SCREEN WAS FULLY FUNCTIONAL AND WAS FULLY ILLUMINATED WITH NO VISIBLE SIGNS OF DISCOLORATION. THE ALLEGATION THAT THE PUMP CONTRIBUTED TO THE PATIENT'S HYPERGLYCEMIA WAS NOT OBSERVED AND COULD NOT BE CONFIRMED DURING THE INVESTIGATION.

Additional Manufacturer Narrative · 1

THE PUMP HAS NOT BEEN RETURNED TO ANIMAS. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Additional Manufacturer Narrative · 1

FOLLOW UP #2 SUBMITTED: (B)(4) 2013. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE.

Description of Event or Problem · 1

THE PATIENT CONTACTED ANIMAS ON (B)(4) 2013 REPORTING A BLOOD GLUCOSE LEVEL OF 567 MG/DL WITH LETHARGY AND MODERATELY INCREASED THIRST. THE PATIENT REPORTED BOLUSING ALL DAY BUT BLOOD GLUCOSE LEVELS ARE ONLY DOWN TO 425 MG/DL. THERE WAS NO ADDITIONAL INFORMATION PROVIDED. THIS REPORT IS MADE BASED ON THE ALLEGATION THAT THE PATIENT EXPERIENCED HYPERGLYCEMIA WHILE USING INSULIN PUMP THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
162356 ONETOUCHPING GLUCOSEMGMTSYSTEM INSULIN INFUSION PUMP LZG ANIMAS CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 52 YR Life Threatening